ANAHEIM, Calif.—Cryoablation is at least as effective external beam radiation therapy (EBRT) for treating localized prostate tumors, according to the first North American randomized clinical trial ...

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer Men with prostate cancer stage cT1c-T2bN0M0, ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

When most people hear “radiation” as a method of treating cancer, they think of external beam radiation therapy, which comes from a machine that aims radiation at the cancer. However, new, targeted ...

St. Louis, Nov. 6, 2001 — Treating prostate cancer with implanted radioactive “seeds” may yield more side effects than previously thought. Researchers at Washington University School of Medicine in St ...

The risk for biochemical recurrence of prostate cancer after external beam radiation therapy varies by prostate cancer risk category. Investigators who studied men who underwent primary external beam ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

Men with prostate cancer stage cT1c-T2bN0M0, Gleason Score (GS) 2-6 and prostate-specific antigen (PSA) 10-20 or GS 7, and PSA < 10 were eligible. The COMBO arm was EBRT (45 Gy in 25 fractions) to ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...